Adam Miller

Senior Writer

Adam Miller is a senior health writer with CBC News. He's covered health, politics and breaking news extensively in Canada, in addition to several years reporting on news and current affairs throughout Asia.

Latest from Adam Miller

Second Opinion

How vaccines can crush the variants and make reopening permanent in Canada

Canada is poised to battle back more contagious coronavirus variants that threaten to jeopardize reopening plans across the country due to a huge uptick in vaccine supply, a willingness from Canadians to get the shots and some promising new vaccine research. 
Analysis

Canada still lacks national guidance for fully vaccinated Canadians as travel restrictions ease

Canada still hasn’t provided clear guidance to fully vaccinated Canadians on what they can and can’t do safely as the number of second doses of COVID-19 vaccines ramps up across the country and travel restrictions are set to ease.
Second Opinion

Race between vaccines and variants is back on as B.1.617 takes hold in Canada

A new variant is taking hold in Canada, but our vaccine supply is ramping and second doses are accelerating across the country. So how at risk are we from B.1.617, and how concerned should Canadians be as we inch closer to reopening much of the country?
Exclusive

Canada recommends mixing and matching AstraZeneca, Pfizer and Moderna COVID-19 vaccines

Canada is changing its guidelines on mixing and matching second doses of COVID-19 vaccines and is now advising Canadians to combine either the AstraZeneca-Oxford, Pfizer-BioNTech or Moderna shots interchangeably in certain situations.
Second Opinion

Why experts say 2nd vaccine doses should be rolled out now

Some experts say Canada should shift to prioritizing second doses of COVID-19 vaccines now due to an increase in supply, a drop in COVID-19 levels and the growing threat of more contagious coronavirus variants that threaten to jeopardize the progress we’ve made.
Analysis

Researchers claim mystery of rare blood clots tied to COVID-19 vaccines solved, but experts urge caution

A German research team has put forward a potential solution to prevent the rare, serious blood clots caused by the AstraZeneca and Johnson & Johnson COVID-19 vaccines, but other scientists warn it's too early to draw conclusions about the mechanism behind the potentially deadly condition.
Second Opinion

Canada is gearing up to reopen. Can it last?

Much of Canada is on the verge of reopening again, with hard-hit provinces lifting lockdowns and mapping out a path to something vaguely resembling normal, while trying desperately to avoid making the mistakes of the past.
Analysis

Canada's change to Pfizer vaccine storage temperature has major implications on rollout

Health Canada says the Pfizer-BioNTech COVID-19 vaccine can now be stored at typical refrigerator temperatures for weeks longer than previously thought, a move that could have major implications on the rollout of vaccines in Canada and around the world.
Second Opinion

Why Canada could soon turn the corner in the pandemic — even if it doesn't feel like it yet

Vaccines are now rolling out across Canada at a rapid pace as supply has finally begun to catch up with demand. While we're still far from returning to normal life, Canadians are more and more protected from the worst of COVID-19 with each passing day.

Top Canadian WHO adviser under fire after downplaying airborne threat of COVID-19

An influential Canadian doctor and top adviser to the World Health Organization has come under fire for controversial comments downplaying the risk of airborne spread of the coronavirus and claiming N95 masks can cause “harms” — including acne.

now